首页> 外文期刊>Bone marrow transplantation >Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience.
【24h】

Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience.

机译:匹配相关同种异体干细胞移植在Fanconi贫血的沙特患者中:10年的经验。

获取原文
获取原文并翻译 | 示例
       

摘要

Allogeneic SCT is curative for bone marrow failure in Fanconi anemia (FA) patients but the optimal conditioning regimen is undetermined. We report here our experience with 56 FA patients who underwent allogeneic matched related SCT. The conditioning regimen varied according to time of SCT and disease status at SCT; 22 patients (group A) received Cy 20 mg/kg, thoraco-abdominal radiation and antithymocyte globulins (ATG); and 34 patients (group B) received Cy 60 mg/kg and ATG. Median time to engraftment was similar (14 days) in both groups. Hemorrhagic cystitis was significantly more common in group B. Overall survival and event-free survival of all patients were 85 and 78.3% respectively. For groups A and B respectively, overall survival was 72.5 and 96.9% (P=0.013); and event-free survival was 72.5 and 82.3% (P=0.3). The use of the nonradiation Cy/ATG regimen in matched related SCT for FA patients offers better overall and event-free survival.
机译:同种异体SCT可以治愈范可尼贫血(FA)患者的骨髓衰竭,但尚不确定最佳的调节方案。我们在这里报告了56名接受同种异体匹配相关SCT的FA患者的经验。适应方案根据SCT的时间和SCT的疾病状况而有所不同。 22例患者(A组)接受Cy 20 mg / kg,胸腹照射和抗胸腺细胞球蛋白(ATG); B组34例患者接受Cy 60 mg / kg和ATG。两组的中位植入时间相似(14天)。出血性膀胱炎在B组中更为常见。所有患者的总生存率和无事件生存率分别为85%和78.3%。 A组和B组的总生存率分别为72.5%和96.9%(P = 0.013);无事件生存率分别为72.5和82.3%(P = 0.3)。在FA患者的相关SCT中使用非辐射Cy / ATG方案可提供更好的总体生存率和无事件生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号